Recent studies have also established that increased upregulation of hepatic LPL is strongly associated with NAFLD due to its rate-controlling function in plasma triglyceride hydrolysis and incorporation into tissues [40,41]. The gene discussed is LPL; the disease is metabolic dysfunction-associated steatotic liver disease.